tiprankstipranks
Altimmune’s Innovative Approach to MASH and Obesity: A Promising Future with Pemvidutide
PremiumRatingsAltimmune’s Innovative Approach to MASH and Obesity: A Promising Future with Pemvidutide
13d ago
Altimmune Reports 2024 Financial Results and R&D Progress
Premium
Company Announcements
Altimmune Reports 2024 Financial Results and R&D Progress
13d ago
Altimmune reports Q4 EPS (33c), consensus (34c)
Premium
The Fly
Altimmune reports Q4 EPS (33c), consensus (34c)
13d ago
Altimmune put volume heavy and directionally bearish
PremiumThe FlyAltimmune put volume heavy and directionally bearish
21d ago
Altimmune call volume above normal and directionally bullish
Premium
The Fly
Altimmune call volume above normal and directionally bullish
29d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Altimmune call volume above normal and directionally bullish
PremiumThe FlyAltimmune call volume above normal and directionally bullish
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100